01-02-2012 | Review Article
Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection?
Case presentation and literature review
Published in: Clinical Rheumatology | Issue 2/2012
Login to get access